Reply to the Editor  by Karmy-Jones, Riyad
cated, a clamp-and-sew technique might be a
reasonable alternative, as suggested by Tra-
chiolis and associates.4 In a selected group
initial nonoperative management and stabili-
zation with -blockers while other comor-
bidities are addressed, followed by elective
repair, might be a reasonable option.
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Reply to the Editor:
We appreciate the kind comments made by
Dr Murala and colleagues, and we agree
with the operative technique and indica-
tions they describe. They have highlighted
an ongoing issue with respect to managing
traumatic aortic disruption in a patient who
has not finished growing. Not only do late
complications of erosion need to be con-
sidered, but we wonder whether the stented
aorta will be prevented from growing, lead-
ing in later life to possible coarcation phys-
iology. Thus as we and others have noted,
endovascular approaches to this problem
need to be incorporated into an algorithm
that includes open repair, medical manage-
ment, or both. We would argue that endo-
vascular stenting be considered if there are
contraindications to operative repair and to
medical management (recognizing that dif-
ferent surgeons and centers might vary in
what is considered a contraindication). Fur-
thermore, because the vast majority of pedi-
atric patients will be candidates only for cuff
extenders or contralateral limbs, these should
be used only if they can be applied predom-
inantly on the “straight” portion of the de-
scending aorta (to minimize endoleak) and if
the proximal points of endografts are not so
close to the left common carotid artery that
any subsequent operation would require an
anterior arch approach.
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I am afraid of using aprotinin
because they say so?
To the Editor:
Cardiothoracic surgeons have become more
aware of the worse outcomes associated with
aprotinin after cardiac surgery, as discussed
in the article by Mangano and colleagues1
published in the New England Journal of
Medicine. It remains an observational study
that, as the authors point out, is in need of
randomized studies. The main concern of
the authors that has not been addressed is
the analysis of a larger sample size in the
aprotinin group compared with that for
other antifibrinolytics. The weighted aver-
age effect of a large sample size can have a
larger effect when outcomes are analyzed.
I will address further potential con-
founding factors by Mangano and col-
leagues.1 The authors did not control for
preoperative hemoglobin count. Zindrou
and associates2 reported on a cohort of
2058 patients and demonstrated that a pre-
operative hemoglobin concentration of 10
g/L or less had a 5-fold higher in-hospital
mortality rate after coronary artery bypass
grafting mortality rates seen in those with a
higher hemoglobin concentration, despite
having had blood transfusions. Maintaining
a patient’s hematocrit value within the nor-
mal range and avoiding extremes is impor-
tant. The main surgical factor that affects
outcome in coronary artery bypass grafting
is anastomosis of the internal thoracic ar-
tery to the left anterior descending artery.
Moreover, the absence of critical disease in
other vessels also affected outcome.3 Man-
gano and associates1 also provided no in-
formation about the mean number of grafts
per patient, perioperative blood loss, blood-
saving techniques, and “transfusion trig-
ger.” These issues are important because
there is a dose-dependent association be-
tween blood transfusion and the develop-
ment of severe postoperative infection and
death in patients undergoing cardiac sur-
Figure 1. Aortogram performed from the right brachial route demonstrating a pseudoan-
eurysm of the proximal descending aorta just distal to the origin of the left subclavian
artery. There is no extravasation.
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